MENU
ADAG
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Adagene (ADAG) Earnings Date & Reports

Adagene Inc is a platform-driven, clinical-stage biotechnology company focused on the discovery and development of novel antibody-based cancer immunotherapies... Show more

A.I. Advisor
published Earnings

ADAG is expected to report earnings to fall 69.23% to -7 cents per share on December 02

Adagene ADAG Stock Earnings Reports
Q3'26
Est.
$-0.08
Q2'26
Missed
by $0.07
Q1'26
Beat
by $0.15
Q4'25
Beat
by $0.15
Q2'25
Beat
by $0.10
The last earnings report on August 12 showed earnings per share of -25 cents, missing the estimate of -18 cents. With 223.12K shares outstanding, the current market capitalization sits at 214.86M.